Oramed Pharmaceuticals (ORMP) Q2 2025 Earnings

May 15Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.48
-0.25
-0.01
0.22

Details

Expected EPS
-0.01
Actual EPS
-0.19
Surprise EPS
-0.18
Surprise Percent
-1,800%

Description

⁨Oramed Pharmaceuticals⁩ (⁦ORMP⁩) has reported earnings of ⁦-0.19⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts